Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00819481 · ClinicalTrials.gov registry record
Post-Market Study of the 3DKnee™ System
A clinical trial, sponsored by Encore Medical, L.P..
- Completed
- Registry status
- 229
- Enrollment target
NCT00819481: Completed study, sponsored by Encore Medical, L.P..
NCT00819481 is a clinical trial that has completed, run by Encore Medical, L.P.. The registered enrollment target is 229 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00819481 has completed, sponsored by Encore Medical, L.P..
- COMPLETED
- Registry status
- 229 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the use and efficacy of the 3DKnee™ System for total knee replacement surgery.
Interventions
- DEVICE 3DKnee™ System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 229 participants |
| Start Date | 2009-02 |
| Est. Completion | 2018-10 |
What the finished NCT00819481 record still lists
NCT00819481 is an observational study that tracks outcomes without assigning an intervention. The registered 229 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which 3DKnee™ System is the first listed.
NCT00819481 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00819481 about?
NCT00819481 is a clinical study titled "Post-Market Study of the 3DKnee™ System". The purpose of this study is to evaluate the use and efficacy of the 3DKnee™ System for total knee replacement surgery.
What is the current status of trial NCT00819481?
This trial is currently completed. The enrollment target is 229 participants. The study started on 2009-02. Estimated completion is 2018-10.
What interventions are being tested in trial NCT00819481?
The interventions under investigation include: 3DKnee™ System (DEVICE).
Who is sponsoring clinical trial NCT00819481?
This trial is sponsored by Encore Medical, L.P., which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02710253 · 230 participants · Phase 2
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
- NCT02777879 · 230 participants
Lung Microbiome and Inflammation in Early COPD
- NCT03824483 · 230 participants · Phase 2
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
- NCT03833622 · 230 participants · NA
Shared Decision Making to Improve Goals of Care in the ED
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia